1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Resectable Soft Tissue Sarcoma: new trials by email Literature Review of Resectable Soft Tissue Sarcoma trials Research Report on Resectable Soft Tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma Navtemadlin, Radiation Therapy, Surgical Procedure - Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma | Phase 1 | Completed | National Cancer Institute (NCI) | 39 | 2018-06-20 | 2025-09-23 |
Sarcoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective and Soft Tissue (1)
2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid (1) · Radiation (1) · Radiotherapy (1) · Surgical Procedures, Operative (1) · navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid (1)
National Cancer Institute (NCI) (1)
United States (1)
Meng X Welliver (1)
U10CA180868 (1)